Rhelion Subsidiary Filament Health Signs Psilocybin Supply Deal for Belgian Compassionate Use Program
Rhelion Life Sciences' wholly owned subsidiary Filament Health signed a supply and licensing agreement with Belgian psychiatric hospital operator Epsylon. Filament will supply its botanical psilocybin drug candidate PEX010 for a compassionate use program targeting treatment-resistant depression. The program requires Be